Literature DB >> 4059755

Hospital charges for antibiotics.

J D McCue, C Hansen, P Gal.   

Abstract

Hospital charges for intravenous antibiotics were obtained in a survey of 71 hospitals in 25 U.S. cities. Only 56.3% of the hospitals used their actual drug acquisition cost to calculate patient charges; the remainder used a base price derived from one of the wholesale price guides, which often seriously overstate the cost of antibiotics. Sixty-eight percent added a markup, averaging 134.5%, and 63.4% added a dispensing fee, averaging $5.47. A relatively high-dose, single-antibiotic regimen costs patients $50-$150 per day, independent of dose-preparation charges (average, $9.09 per dose) for a piggyback-type system or intravenous line-related charges. Antibiotics were least expensive in large hospitals and in those located in the northeastern United States. Charges for antibiotics are often inconsistently calculated, vary enormously among hospitals, and may be unfair to patients and confusing to physicians. Cost-conscious prescribing of antibiotics by physicians would be facilitated by a more consistent relationship between charges and true costs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4059755     DOI: 10.1093/clinids/7.5.643

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  5 in total

1.  A multidisciplinary hospital-based antimicrobial use program: Impact on hospital pharmacy expenditures and drug use.

Authors:  S Salama; C Rotstein; L Mandell
Journal:  Can J Infect Dis       Date:  1996-03

Review 2.  Pharmacoeconomics of intravenous drug administration.

Authors:  S E Parker; P G Davey
Journal:  Pharmacoeconomics       Date:  1992-02       Impact factor: 4.981

3.  Transplant infections--controversies about cost related issues.

Authors:  L S Young; M A Bermudez
Journal:  Bull N Y Acad Med       Date:  1987 Jul-Aug

4.  Cost of gentamicin assays carried out by microbiology laboratories.

Authors:  P F Vacani; M M Malek; P G Davey
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

5.  The cost effectiveness of amoxicillin/clavulanic acid as antibacterial prophylaxis in abdominal and gynaecological surgery.

Authors:  P G Davey; S E Parker; I K Crombie; M Jaderberg
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.